1 unchanged sentence
The exhibits listed below are filed or furnished as part of this report.
−Removed: First Amendment to License Agreement, effective as of March 16,2020, by and between Aquestive Therapeutics, Inc, and Sunovion Pharmaceuticals Inc.
−Removed: (formerly, Cynapsus Therapeutics, Inc.) (filed as Exhibit 10.1 to the Current Report on Form
−Removed: 10-K and to the Current Report on Form 8-K of the Company filed on March 20, 2020 and incorporated by reference herein).
−Removed: Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a), as amended, under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
−Removed: Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a), as amended, under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
+Added: Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a), as amended, under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of
+Added: 2002 (filed herewith).
+Added: Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a), as amended, under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of
+Added: 2002 (filed herewith).
Certification of Principal Executive Officer Pursuant to 18 U.S.C.
9 unchanged sentences
*Portions of this exhibit have been omitted pursuant to Rule 601(b)(10) of Regulation S-K.
−Removed: The omitted information is not material and would likely cause competitive harm to the registrant if
−Removed: publicly disclosed.
−Removed: Pursuant to the requirements of the Securities Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in
−Removed: the County of Somerset, State of New Jersey.
+Added: The omitted information is not material and would likely cause competitive harm to the registrant if publicly disclosed.
+Added: Pursuant to the requirements of the Securities Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned,
+Added: thereunto duly authorized, in the County of Somerset, State of New Jersey.
Aquestive Therapeutics, Inc.
+Added: August 4, 2020
President and Chief Executive Officer
(Principal Executive Officer)
+Added: August 4, 2020
Chief Financial Officer
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.